for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Irras AB

IRRAS.ST

Latest Trade

6.85SEK

Change

0.02(+0.29%)

Volume

75,084

Today's Range

6.66

 - 

6.89

52 Week Range

5.25

 - 

28.31

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
6.83
Open
6.89
Volume
75,084
3M AVG Volume
5.79
Today's High
6.89
Today's Low
6.66
52 Week High
28.31
52 Week Low
5.25
Shares Out (MIL)
66.28
Market Cap (MIL)
454.03
Forward P/E
-2.77
Dividend (Yield %)
--

Latest Developments

More

Irras Q2 Net Sales At SEK 1.2 Million

Irras Q2 EBIT Loss Narrows To SEK 31.2 Mln

IRRAS: Extension Of CE Mark For IRRAflow System Until May 2024

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Irras AB

Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company’s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.

Industry

Medical Equipment & Supplies

Contact Info

Vasagatan 16

111 20

Sweden

+46.8.102115170

https://irras.com/

Executive Leadership

Marios Fotiadis

Independent Chairman of the Board

Kleanthis G. Xanthopoulos

President, Chief Executive Officer, Director

Sabina Berlin

Chief Financial Officer

Adam Sampson

Vice President - Product Excellence

Kellie Fontes

Senior Director, Human Capital

Key Stats

2.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, SEK)

2019

0.0K

2020(E)

0.0K
EPS (SEK)

2019

-5.295

2020(E)

-2.470
Price To Earnings (TTM)
--
Price To Sales (TTM)
64.97
Price To Book (MRQ)
1.78
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
4.79
LT Debt To Equity (MRQ)
0.12
Return on Investment (TTM)
-60.41
Return on Equity (TTM)
-54.95

Latest News

Latest News

BRIEF-IRRAS: COVID-19 Delays Short-term Revenue

* COVID-19 DELAYS SHORT TERM REVENUE, WHILE THE COMMERCIAL LAUNCH OF IRRAFLOW AND HUMMINGBIRD PROGRESSES

BRIEF-Irras Approved For Listing On Nasdaq Stockholm

* FIRST DAY OF LISTING ON NASDAQ STOCKHOLM IS 20 MAY 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Irras Q1 EBIT Loss Narrows To SEK 35.2 Mln

* Q1 EBIT LOSS SEK 35.2 MILLION VERSUS LOSS SEK 39.1 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Irras AB To List On Nasdaq Stockholm

* IRRAS AB - FIRST DAY OF TRADING OF IRRAS' SHARES ON NASDAQ STOCKHOLM IS EXPECTED TO BE WEDNESDAY, 20 MAY 2020

BRIEF-Irras Gets Approval For Loan From US Stimulus Package

* IRRAS RECEIVES APPROVAL FOR LOAN FROM US STIMULUS PACKAGE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-IRRAS Announces Outcome Of Fully Guaranteed Rights Issue Of 217 MSEK

* IRRAS ANNOUNCES OUTCOME OF THE FULLY GUARANTEED RIGHTS ISSUE OF 217 MSEK

BRIEF-Irras Resolves On Fully Underwritten Rights Issue Of SEK 217 Mln

* IRRAS' BOARD OF DIRECTORS RESOLVES ON A FULLY UNDERWRITTEN RIGHTS ISSUE OF APPROXIMATELY SEK 217 MILLION

BRIEF-Irras Q4 EBIT Loss Narrows To SEK 35.7 Million

* PUBLISHES INTERIM REPORT FOR THE PERIOD JANUARY TO DECEMBER 2019

BRIEF-IRRAS Completes Directed Share Issue Of Around SEK 106 Mln

* SAID ON WEDNESDAY THAT CO HAS SUCCESSFULLY COMPLETED A DIRECTED SHARE ISSUE

BRIEF-IRRAS Announces Voluntary Recall On IRRAflow Device

* IRRAS ANNOUNCES VOLUNTARY RECALL ON ITS IRRAFLOW™ DEVICE DUE TO AN ISOLATED INCIDENT OF A BATTERY MANUFACTURING FAILURE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up